Related Experiment Video
Updated: Jun 27, 2026

05:36
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma
Liang Cheng1, Gregory T MacLennan, Shaobo Zhang
1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. liang_cheng@yahoo.com
Summary
Multifocal clear cell renal cell carcinoma tumors often arise independently. Genomic analysis revealed distinct clonal origins in nearly half of the cases studied, suggesting separate development pathways for these kidney cancers.
Area of Science:
- Oncology
- Genetics
- Urology
Background:
- Multifocal clear cell renal cell carcinoma (ccRCC) presents a clinical challenge due to the presence of multiple tumors within a single kidney.
- Understanding the clonal relationship between these spatially distinct tumors is crucial for accurate diagnosis and treatment strategies.
Purpose of the Study:
- To investigate the genomic signatures of multifocal ccRCC.
- To determine if multiple tumors within the same kidney share a common clonal origin or arise independently.
Main Methods:
- Analysis of 62 tumors from 26 patients with multifocal ccRCC.
- Loss of heterozygosity (LOH) analysis using microsatellite markers on chromosomes 3p, 7q, 8p, 9p, and 17p.
- X chromosome inactivation analysis in female patients and 3p deletion status by fluorescence in situ hybridization (FISH).
Main Results:
- 73% of patients showed allelic loss in at least one microsatellite locus across separate tumors.
- Discordant patterns of allelic loss and 3p deletion were observed in 7 and 6 cases, respectively.
- Evidence of independent tumor origin was found in 46% of the cases studied.
Conclusions:
- A significant proportion of multifocal ccRCC cases demonstrate spatially separate tumors of independent clonal origin.
- These findings suggest that multiple ccRCCs within a kidney can arise through distinct oncogenic pathways.
